Bio-Rad Laboratories Inc (BIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($108.10 Million) by net assets ($6.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIO net asset quality score to measure how much of total assets are equity-financed.
Bio-Rad Laboratories Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Bio-Rad Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Bio-Rad Laboratories Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bio-Rad Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AutoNation Inc
NYSE:AN
|
0.010x |
|
Linde India Limited
NSE:LINDEINDIA
|
0.093x |
|
Cpi Property Group SA
XETRA:O5G
|
0.029x |
|
Enpro Industries
NYSE:NPO
|
0.025x |
|
Samsung Engineering
KO:028050
|
-0.059x |
|
Getinge AB ser. B
ST:GETI-B
|
0.036x |
|
Open Text Corp
TO:OTEX
|
0.079x |
|
GDS Holdings Limited
F:G40
|
0.035x |
Annual Cash Flow Conversion Efficiency for Bio-Rad Laboratories Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Rad Laboratories Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see BIO market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.45 Billion | $532.20 Million | 0.071x | +3.04% |
| 2024-12-31 | $6.57 Billion | $455.20 Million | 0.069x | +61.54% |
| 2023-12-31 | $8.74 Billion | $374.94 Million | 0.043x | +112.11% |
| 2022-12-31 | $9.62 Billion | $194.45 Million | 0.020x | -57.85% |
| 2021-12-31 | $13.69 Billion | $656.52 Million | 0.048x | -18.98% |
| 2020-12-31 | $9.88 Billion | $584.97 Million | 0.059x | -25.58% |
| 2019-12-31 | $5.76 Billion | $457.90 Million | 0.080x | +12.04% |
| 2018-12-31 | $4.02 Billion | $285.49 Million | 0.071x | +99.82% |
| 2017-12-31 | $2.93 Billion | $104.14 Million | 0.036x | -57.58% |
| 2016-12-31 | $2.58 Billion | $216.07 Million | 0.084x | +12.04% |
| 2015-12-31 | $2.49 Billion | $186.21 Million | 0.075x | -40.22% |
| 2014-12-31 | $2.19 Billion | $273.31 Million | 0.125x | +61.71% |
| 2013-12-31 | $2.19 Billion | $169.14 Million | 0.077x | -41.50% |
| 2012-12-31 | $2.02 Billion | $266.48 Million | 0.132x | -12.22% |
| 2011-12-31 | $1.74 Billion | $262.74 Million | 0.151x | +2.71% |
| 2010-12-31 | $1.54 Billion | $225.91 Million | 0.147x | -42.29% |
| 2009-12-31 | $1.28 Billion | $325.07 Million | 0.254x | +42.17% |
| 2008-12-31 | $1.07 Billion | $191.37 Million | 0.179x | -9.34% |
| 2007-12-31 | $971.69 Million | $191.58 Million | 0.197x | +36.67% |
| 2006-12-31 | $819.54 Million | $118.23 Million | 0.144x | -12.34% |
| 2005-12-31 | $657.97 Million | $108.28 Million | 0.165x | -20.20% |
| 2004-12-31 | $596.89 Million | $123.09 Million | 0.206x | -19.89% |
| 2003-12-31 | $495.81 Million | $127.64 Million | 0.257x | -6.75% |
| 2002-12-31 | $383.09 Million | $105.76 Million | 0.276x | -21.23% |
| 2001-12-31 | $283.88 Million | $99.50 Million | 0.350x | +253.59% |
| 2000-12-31 | $244.62 Million | $24.25 Million | 0.099x | -51.52% |
| 1999-12-31 | $220.10 Million | $45.00 Million | 0.204x | +60.49% |
| 1998-12-31 | $214.30 Million | $27.30 Million | 0.127x | +18.76% |
| 1997-12-31 | $196.70 Million | $21.10 Million | 0.107x | -40.71% |
| 1996-12-31 | $183.50 Million | $33.20 Million | 0.181x | -25.59% |
| 1995-12-31 | $157.10 Million | $38.20 Million | 0.243x | -34.65% |
| 1994-12-31 | $129.80 Million | $48.30 Million | 0.372x | +82.42% |
| 1993-12-31 | $110.30 Million | $22.50 Million | 0.204x | +446.18% |
| 1992-12-31 | $107.10 Million | $4.00 Million | 0.037x | -17.29% |
| 1991-12-31 | $90.80 Million | $4.10 Million | 0.045x | -69.74% |
| 1990-12-31 | $81.10 Million | $12.10 Million | 0.149x | +4.90% |
| 1989-12-31 | $68.90 Million | $9.80 Million | 0.142x | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more